|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/22 | |
| A61K 9/36 | |||
| A61K 31/137 |
| (11) | Number of the document | 2034970 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07777373.7 |
| Date of filing the European patent application | 2007-06-01 | |
| (97) | Date of publication of the European application | 2009-03-18 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/013050 |
| Date | 2007-06-01 |
| (87) | Number | WO 2007/143158 |
| Date | 2007-12-13 |
| (30) | Number | Date | Country code |
| 810021 P | 2006-06-01 | US | |
| 874830 P | 2006-12-14 | US |
| (72) |
MONTEITH, David, US
O`MULLANE, John, US
REO, Joseph P., US
NOWAK, Robert T., US
WAN, Jiansheng, US
KABIR, Mohammed A., US
ABUTARIF, Malaz A., US
FRITZ, Glenn E., US
|
| (73) |
MSD Consumer Care, Inc.,
3030 Jackson Avenue, Memphis TN 38151,
US
|
| (54) | SUSTAINED RELEASE PHARMACEUTICAL FORMULATION COMPRISING PHENYLEPHRINE |
| SUSTAINED RELEASE PHARMACEUTICAL FORMULATION COMPRISING PHENYLEPHRINE |